Literature DB >> 18574219

Premature ovarian "failure" in the adolescent.

Robert W Rebar1.   

Abstract

Premature ovarian "failure" (POF) is an enigmatic and heterogeneous disorder characterized by amenorrhea, hypoestrogenism, and hypergonadotropinism that occurs in women under the age of 40 years. The predominant causes are different in the adolescent, and more of these causes are associated with permanent cessation of ovarian function. It would seem that the more common causes of POF in adolescents include cytogenetic abnormalities involving the X chromosome, ovarian dysfunction occurring in association with other autoimmune endocrine disturbances, and chemotherapy and/or radiation therapy given for any of a number of malignancies. Special challenges in the adolescent beyond establishing the diagnosis include counseling the young woman and her family and discussing the possibility of future pregnancy. Lifelong therapy must be addressed as well. Any discussion of POF raises numerous unanswered questions that should be the focus of future research.

Entities:  

Mesh:

Year:  2008        PMID: 18574219     DOI: 10.1196/annals.1429.000

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

1.  Novel Inactivating Mutation of the FSH Receptor in Two Siblings of Indian Origin With Premature Ovarian Failure.

Authors:  S Katari; M A Wood-Trageser; H Jiang; E Kalynchuk; R Muzumdar; S A Yatsenko; A Rajkovic
Journal:  J Clin Endocrinol Metab       Date:  2015-04-15       Impact factor: 5.958

2.  A novel homozygous frame-shift variant in the LHCGR gene is associated with primary ovarian insufficiency in a Pakistani family.

Authors:  A C Zielen; M J Khan; N Pollock; H Jiang; J Ahmed; R Nazli; M Jabeen; A Yatsenko; A Rajkovic
Journal:  Clin Genet       Date:  2018-07-17       Impact factor: 4.438

3.  Inhibin α-subunit N terminus interacts with activin type IB receptor to disrupt activin signaling.

Authors:  Jie Zhu; S Jack Lin; Chao Zou; Yogeshwar Makanji; Theodore S Jardetzky; Teresa K Woodruff
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

4.  Human cord blood mononuclear cell transplantation for the treatment of premature ovarian failure in nude mice.

Authors:  Jianhong Dang; Zhijun Jin; Xiaojun Liu; Dian Hu; Zhifeng Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  Transplantation of human menstrual blood stem cells to treat premature ovarian failure in mouse model.

Authors:  Te Liu; Yongyi Huang; Jian Zhang; Wenxing Qin; Huiying Chi; Jiulin Chen; Zhihua Yu; Chuan Chen
Journal:  Stem Cells Dev       Date:  2014-04-25       Impact factor: 3.272

Review 6.  Instructing an embryonic stem cell-derived oocyte fate: lessons from endogenous oogenesis.

Authors:  Cory R Nicholas; Shawn L Chavez; Valerie L Baker; Renee A Reijo Pera
Journal:  Endocr Rev       Date:  2009-04-14       Impact factor: 19.871

7.  Induction of estrogen-sensitive epithelial cells derived from human-induced pluripotent stem cells to repair ovarian function in a chemotherapy-induced mouse model of premature ovarian failure.

Authors:  Te Liu; Wenxing Qin; Yongyi Huang; Yanhui Zhao; Jiejun Wang
Journal:  DNA Cell Biol       Date:  2013-09-14       Impact factor: 3.311

8.  CD44+/CD105+ human amniotic fluid mesenchymal stem cells survive and proliferate in the ovary long-term in a mouse model of chemotherapy-induced premature ovarian failure.

Authors:  Te Liu; Yongyi Huang; Lihe Guo; Weiwei Cheng; Gang Zou
Journal:  Int J Med Sci       Date:  2012-09-11       Impact factor: 3.738

Review 9.  Pathogenesis and causes of premature ovarian failure: an update.

Authors:  Mahbod Ebrahimi; Firoozeh Akbari Asbagh
Journal:  Int J Fertil Steril       Date:  2011-09-23

10.  Growth hormone treatment of premature ovarian failure in a mouse model via stimulation of the Notch-1 signaling pathway.

Authors:  T E Liu; Suwei Wang; Lina Zhang; Lihe Guo; Zhihua Yu; Chuan Chen; Jin Zheng
Journal:  Exp Ther Med       Date:  2016-05-10       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.